Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

MALT1 protein inhibitor

DRUG CLASS:

MALT1 protein inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

CARD11 mutation	Diffuse Large B Cell Lymphoma	CARD11 mutation	Diffuse Large B Cell Lymphoma	CTX-177 Sensitive: D – Preclinical CTX-177 Sensitive : D	CTX-177 Sensitive: D – Preclinical CTX-177 Sensitive : D
CARD11 mutation	Diffuse Large B Cell Lymphoma	CARD11 mutation	Diffuse Large B Cell Lymphoma	JNJ-6633 Sensitive: D – Preclinical JNJ-6633 Sensitive : D	JNJ-6633 Sensitive: D – Preclinical JNJ-6633 Sensitive : D
CD79B mutation	Diffuse Large B Cell Lymphoma	CD79B mutation	Diffuse Large B Cell Lymphoma	JNJ-6633 Sensitive: D – Preclinical JNJ-6633 Sensitive : D	JNJ-6633 Sensitive: D – Preclinical JNJ-6633 Sensitive : D
CD79B mutation	Diffuse Large B Cell Lymphoma	CD79B mutation	Diffuse Large B Cell Lymphoma	JNJ-6633 + JNJ-4681 Sensitive: D – Preclinical JNJ-6633 + JNJ-4681 Sensitive : D	JNJ-6633 + JNJ-4681 Sensitive: D – Preclinical JNJ-6633 + JNJ-4681 Sensitive : D